EP3155017

IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    28.5.2015
  • :
    10.1.2024
  • :
    15798956.7
  • :
    27.5.2035
  • :
    IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE

28.5.2015
10.1.2024
  • :
    Mederis Diabetes, LLC
  • :
    7515 Guinevere Drive, Sugar Land, Texas 77479, US
  • :
    NESTOR, John, J.
  • :
    Encinitas, CA 92024, US
  • :
    201462004156 P
  • :
    28.5.2014
  • :
    US
  • :
    US2015033042
  • :
    28.5.2015
  • :
    C07K 19/00, C07K 14/605, A61K 38/26, A61K 47/50, A61P 31/10